Evidence map›Paper›PMID 32747405›Full record

Observational studyDiabetes care2020

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function.

Guy S Taylor, Kieran Smith, Tess E Capper, Jadine H Scragg, Ayat Bashir, Anneliese Flatt, Emma J Stevenson, Timothy J McDonald, Richard A Oram, James A Shaw and 1 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Pancreatic islet reserve in type 1 diabetes.Annals of the New York Academy of Sciences · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Guy S TaylorPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, U.K.
Kieran SmithPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, U.K.
Tess E CapperPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, U.K.
Jadine H ScraggPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, U.K.
Ayat BashirTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, U.K.
Anneliese FlattTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, U.K.
Emma J StevensonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, U.K.
Timothy J McDonaldNational Institute for Health Research Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0003-3559-6660
Richard A OramNational Institute for Health Research Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0003-3581-8980
James A ShawTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, U.K. daniel.west@newcastle.ac.uk jim.shaw@ncl.ac.uk.ORCID 0000-0002-2893-3211
Daniel J WestPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, U.K. daniel.west@newcastle.ac.uk jim.shaw@ncl.ac.uk.ORCID 0000-0003-2246-4925
Newcastle University · GBRoyal Devon & Exeter NHS Foundation Trust · GBQueen's University Belfast · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the impact of residual β-cell function on continuous glucose monitoring (CGM) outcomes following acute exercise in people with type 1 diabetes (T1D). RESEARCH DESIGN AND

methodsThirty participants with T1D for ≥3 years were recruited. First, participants wore a blinded CGM unit for 7 days of free-living data capture. Second, a 3-h mixed-meal test assessed stimulated C-peptide and glucagon. Peak C-peptide was used to allocate participants into undetectable (Cpep

resultsCGM parameters were comparable across groups during the free-living observation week. In the 12- and 24-h postexercise periods (12 h and 24 h), the Cpep

conclusionsResidual β-cell function may partially explain the interindividual variation in the acute glycemic benefits of exercise in individuals with T1D. Quantifying C-peptide could aid in providing personalized and targeted support for exercising patients.

Indexed as

Glycemic ControlAdolescentAdultAgedBlood GlucoseBlood Glucose Self-MonitoringC-PeptideDiabetes Mellitus, Type 1ExerciseFemaleHumansHypoglycemiaInsulin-Secreting CellsMaleMiddle AgedYoung AdultBlood GlucoseC-Peptide

Identifiers

PMID32747405
PMCPMC7510016
OpenAlexW3039531850

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.